3 Undervalued Pharmaceuticals Stocks for Wednesday, September 30
Discover the top 3 undervalued Pharmaceuticals stocks for Wednesday, September 30 based on AAII’s Stock Grades.Tudor Pop
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Verano Holdings Corp. engages in the cannabis business in the United States. It is involved in the cultivation, processing, wholesale, and retail distribution of cannabis. The company also designs, builds, and operates cannabis dispensaries. It sells its products under the Encore, Avexia, MÜV, Savvy, Essence, BITS, HYPHEN, Swift Lifts, Verano, and Zen Leaf brand names to medical and adult use markets. The company is headquartered in Chicago, Illinois.
Commentary & Analysis
3 Undervalued Pharmaceuticals Stocks for Friday, August 28
Discover the top 3 undervalued Pharmaceuticals stocks for Friday, August 28 based on AAII’s Stock Grades.Michael Rose
3 Undervalued Pharmaceuticals Stocks for Wednesday, July 15
Discover the top 3 undervalued Pharmaceuticals stocks for Wednesday, July 15 based on AAII’s Stock Grades.Michael Rose
Is Verano Holdings Corp. (VRNO) Stock a Good Investment?
Learn more about Verano Holdings Corp.'s (VRNO) stock grades for Value, Momentum, Growth and Estimate Revisions and determine whether this Pharmaceuticals stock meets your investment needs.Tudor Pop
Does Verano Holdings Corp. (VRNO) Have Momentum?
With data as of June 11, 2026, we examine if Verano Holdings Corp.(VRNO) is consistently building momentum based on AAII's A+ Investor Momentum and Value Scores and Grades.Michael Rose
Financial Summary
| Share Statistics | VRNO | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $381.8 | $519.2 | 35% |
|
| Shares Out (Mil) | 73.0 | 42.8 | 56% |
|
| Institutional Ownership | 4.4% | 82.8% | 4% |
|
| Float (Mil) | 65.7 | 44.4 | 53% |
|
| Beta | 1.44 | 0.71 | 81% |
|
| Avg Daily Volume (000s) | 173 | 394 | 42% |
|
| Price Change (52-week) |
(33.0%) | 60.2% | 28% |
|
| Growth | VRNO | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 29.2% | 6.1% | 89% |
|
| Net Income (5yr) | (54.2%) | (2.0%) | 6% |
|
| EPS (5yr) | (48.0%) | 15.0% | 4 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (18.8%) | (15.1%) | 36% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | na | na | |
| Current EPS | ($0.220) | na | na | |
| Month Ago EPS | ($0.220) | na | na | |
| # Rev Up | 0 | na | na | |
| # Rev Down | 1 | na | na | |
| Three Months Ago EPS | ($0.250) | na | na | |
| Year/Year Chg | 19.6% | na | na | |
| Financials | VRNO | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $836 | $416 | 48% |
|
| Net Income (TTM) (Mil) | ($259) | ($11) | 5% |
|
| EPS (TTM) | ($3.581) | ($0.700) | 10% |
|
| Operating Cash Flow (TTM) (Mil) | $89 | ($7) | 51% |
|
| Net Cash Flow (TTM) (Mil) | $17 | $6 | 60% |
|
| Long-Term Debt (Q1) (Mil) | $471 | $6 | 58% |
|
| Enterprise Value (Q1) (Mil) | $846 | $494 | 39% |
|
| Valuation | VRNO | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.57 | 2.31 | 11% |
|
| P/E | na | 17.4 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | VRNO | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 47.8% | 69.4% | 60% |
|
| Net Margin | (30.9%) | 3.2% | 14% |
|
| ROA | (14.2%) | (22.2%) | 23% |
|
| ROE | (32.2%) | (21.4%) | 19% |
|
| Liabilities to Assets | 60.3% | 32.8% | 54% |
|
| F-Score | 6 | 3 | 67% |
|
Verano Holdings Corp. did not pass any screens on 10/9/2026.
